Grove Biopharma
- Business Model
- B2B
- Website
- grovebiopharma.com
- Total Funding
- $60.0M
- Last Round
- $30.0M Series AMar 2026
- Rounds
- 2
About
Grove Biopharma develops synthetic protein-based medicines targeting cancer, neurodegenerative diseases, and rare disorders.
Summary
Grove Biopharma is a Biotech company. It has raised $60.0M in total across 2 rounds, most recently a $30.0M Series A round in Mar 2026. Investors include DCVC (Data Collab), Andreessen Horowitz and Eli Lilly and Company.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company